ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 154

Dual-Energy Computed Tomography As a Diagnostic Tool for Gout During Intercritical Periods

Gabriel S. Breuer1, Naama Bogot2 and Gideon Nesher3, 1Rheumatology, Shaare Zedek Medical Center, Jerusalem, Israel, 2Radiology, Shaare Zedek Medical Center p o box 3235 Jerusalem, Israel, Israel, 3Internal Medicine, Shaare Zedek Medical Center, Jerusalem, Israel

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: gout and imaging techniques

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Metabolic and Crystal Arthropathies

Session Type: Abstract Submissions (ACR)

Background/Purpose: Dual-energy computed tomography (DECT) is a sensitive method for identifying uric acid deposits in joints and periarticular soft tissues in patients suspected of having gout. Diagnosis of gout cannot be confirmed by polarized microscopy during asymptomatic (intercritical) periods as joint aspiration is not feasible in most cases. We estimated the yield of dual-energy computed tomography (CT) in detection of uric acid tissue deposits during intercritical periods in patients suspected of having gout.

Methods: Patients aged at least 18 years with a history of recurrent, short-lived mono- or oligo-arthralgia or arthritis, referred to the rheumatology clinic for diagnosis of their condition, were included. All had uric acid levels >6 mg/dl and were completely asymptomatic at the time of clinical and radiological evaluations. Patients with a confirmed diagnosis of gout and patients on urate-lowering medicationswere excluded. DECT screened the specific joints and periarticular soft tissues that were previously involved in each case.

Results: 22 patients (18 men, 4 women) were included. Their mean age was 57+17 years. Articular or soft-tissue urate deposits were identified by DECT in 11 cases (50%). Uric acid level did not differ significantly between the groups with or without deposits (8.5+2 and 8.7+1.2 mg/dl, respectively). The table shows the yield of DECT in various anatomic locations:

Area screened

feet

knees

elbows

hands

Number of cases

18

8

1

4

Cases with urate deposits

7

2

0

3

% with urate deposits

39%

25%

0

75%

Conclusion: In asymptomatic hyperuricemic patients with a history of recurrent short-lived mono- or oligo-arthralgia or arthritis, DECT identified urate crystals in 50%, confirming a diagnosis of gout. DECT is a valuable tool in diagnosing gout during intercritical periods.


Disclosure:

G. S. Breuer,
None;

N. Bogot,
None;

G. Nesher,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dual-energy-computed-tomography-as-a-diagnostic-tool-for-gout-during-intercritical-periods/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology